Information Note: External Advisory Review Panel Recommendation on the Notice of Objection for RVD2021-05: Imidacloprid and Its Associated End-Use Products

Following a review of the objections raised by Dr. Christy Morrissey regarding the re-evaluation decision for imidacloprid, Health Canada established an External Advisory Review Panel, tasked to provide objective, science-based advice and recommendations on mesocosm studies and their use in the re-evaluation decision for imidacloprid. The External Advisory Review Panel found that the aquatic effects metric used by Health Canada is appropriate and sufficiently protective of aquatic invertebrate communities…
Read More